Parvo Shield L5E (Canada)This page contains information on Parvo Shield L5E for veterinary use.
The information provided typically includes the following:
- Parvo Shield L5E Indications
- Warnings and cautions for Parvo Shield L5E
- Direction and dosage information for Parvo Shield L5E
Parvo Shield L5EThis treatment applies to the following species:
Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin
For Use in Animals Only
Parvo Shield L5E Indications
For use in healthy swine as an aid in the prevention of disease caused by porcine parvovirus, Erysipelothrix rhusiopathiae, Leptospira canicola, grippotyphosa, hardjo, icterohaemorrhagiae, and pomona. This product has not been tested in pregnant animals.
ADJUVANT: Aluminum hydroxide.
Directions For Use
Shake well before using. Administer 5 mL intramuscularly to gilts and sows 4-6 weeks prior to breeding. Repeat in 3-4 weeks. Revaccinate with a single dose 4-6 weeks prior to each subsequent breeding. Vaccinate boars semiannually.
PrecautionsStore out of direct sunlight at 2°-8°C (35°-46°F). DO NOT FREEZE. Do not mix with other products except as specified on the label. In case of human exposure contact a physician. Use entire contents when first opened. Do not vaccinate within 21 days prior to slaughter. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.
Manufactured by Elanco US Inc., Fort Dodge, IA, USA.
USDA Vet. Biologics Est. Lic. No. 196.
For Elanco Canada Limited, Guelph, Ontario, Canada N1G 4T2; 1-800-265-5475.
Parvo Shield, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
Copyright © 2022 Animalytix LLC. Updated: 2021-11-29